Clinical Trials Directory

Trials / Completed

CompletedNCT02446834

Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

Research of Intensive Lifestyle Intervention for Overweight PCOS Patients With Impaired Glucose Tolerance in Their Metabolic and Reproductive Abnormalities Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
RenJi Hospital · Academic / Other
Sex
Female
Age
14 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Compare the efficacy between intensive lifestyle intervention and drugs (GLP-1 Receptor Agonists, metformin and acarbose) for PCOS patients with early onset diabetes in their metabolic and reproductive abnormalities treatment; clear the treatment effect and mechanism of intensive lifestyle intervention to PCOS.

Detailed description

We designed a non randomized control study to compare the efficacy between intensive lifestyle intervention and drugs (GLP-1 Receptor Agonists, metformin and acarbose) for PCOS patients with early onset diabetes in their metabolic and reproductive abnormalities treatment We planed to enroll 48 patients.Overweight and obese PCOS patients with newly diagnosed IGT; PCOS diagnosis based on 1990 NIH criteria. Overweight / obesity diagnostic criteria according to WHO-WPR. IGT diagnostic criteria according to 1998 WHO diagnostic criteria. Except for serious complications (cardiovascular events and recent significant kidney or lung disease within 3 months), and had high blood pressure (\>160/100mmHg), blood sugar and high blood lipids (glycated hemoglobin\> 11%, triglycerides \>600 mg/dl). Then we devided the 48 patients into 4 groups: intensive lifestyle intervention group, GLP-1 group, metformin group and acarbose group, and each group 12 samples. Each group use specific treatment(showed as the group name) 3 months. Before and after the intervention, the blood samples would be collected to Glucose, Insulin, GLP-1, Glucagon, sex hormones, Blood chemistry for liver and kidney function ect, as well as the image examinations. We will compare the data of each patient, finally identify the treatment effect and mechanism of intensive lifestyle intervention to PCOS.

Conditions

Interventions

TypeNameDescription
BEHAVIORALintensive lifestyle intervention3 months low GI diet and exercise
DRUGGLP-1 Receptor AgonistsUse GLP-1 Receptor Agonists 3 months to treat PCOS
DRUGMetforminUse metformin 3 months to treat PCOS
DRUGAcarboseUse acarbose 3 months to treat PCOS

Timeline

Start date
2015-04-01
Primary completion
2017-12-01
Completion
2018-04-01
First posted
2015-05-18
Last updated
2022-10-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02446834. Inclusion in this directory is not an endorsement.